Total Raised

$85.39M

Investors Count

21

Deal Terms

2

Funding, Valuation & Revenue

13 Fundings

Congenica has raised $85.39M over 13 rounds.

Congenica's latest funding round was a Acquired for on September 2, 2025.

Congenica's 2024 revenue was $35M. Congenica's most recent revenue is from 2024.

Sign up for a free demo to see revenue data from 2024 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/2/2025

Acquired

$XXM

$X.XXB

((X.XXx))

FY XXXX

5

9/19/2023

Biz Plan Competition - II

$0.08M

$XXM

$35M

FY 2024

9/21/2021

Biz Plan Competition

$XXM

0

FY undefined

2

3/3/2021

Series C - II

$XXM

0

FY undefined

10

11/9/2020

Series C

$XXM

$XXM

0

FY undefined

10

Date

9/2/2025

9/19/2023

9/21/2021

3/3/2021

11/9/2020

Round

Acquired

Biz Plan Competition - II

Biz Plan Competition

Series C - II

Series C

Amount

$0.08M

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

$35M

FY 2024

0

FY undefined

0

FY undefined

0

FY undefined

Sources

5

2

10

10

Start free trial
New call-to-action

Congenica Deal Terms

2 Deal Terms

Congenica's deal structure is available for 2 funding rounds, including their Series B from February 27, 2017.

Round

Series B

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Congenica Investors

21 Investors

Congenica has 21 investors. SeqOne invested in Congenica's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/2/2025

9/2/2025

1
Acquired

Corporation

France

9/19/2023

9/19/2023

1
Biz Plan Competition - II

Incubator/Accelerator

Massachusetts

9/21/2021

9/21/2021

1
Biz Plan Competition

Business Plan Competition

United Kingdom

00/00/0000

00/00/0000

QVentures

Subscribe to see more

Venture Capital

United Kingdom

00/00/0000

00/00/0000

Cambridge Innovation Capital

Subscribe to see more

Venture Capital

United Kingdom

First funding

9/2/2025

9/19/2023

9/21/2021

00/00/0000

00/00/0000

Last Funding

9/2/2025

9/19/2023

9/21/2021

00/00/0000

00/00/0000

Investor

QVentures

Cambridge Innovation Capital

Rounds

1
Acquired
1
Biz Plan Competition - II
1
Biz Plan Competition

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Incubator/Accelerator

Business Plan Competition

Venture Capital

Venture Capital

Location

France

Massachusetts

United Kingdom

United Kingdom

United Kingdom

New call-to-action

Compare Congenica to Competitors

Golden Helix Logo
Golden Helix

Golden Helix is a bioinformatics firm that provides genomic data analysis software for the life sciences sector. The company offers tools for the annotation, filtering, interpretation, and reporting of genomic variants. Golden Helix's solutions serve various sectors, including commercial testing labs, hospital labs, human genetic research, and pharmaceutical R&D. It was founded in 1998 and is based in Bozeman, Montana.

Geneyx Logo
Geneyx

Geneyx focuses on sequencing (NGS) data analysis and interpretation within the clinical genome research sector. The company offers services for analyzing and interpreting genetic data from whole genome sequencing (WGS), whole exome sequencing (WES), gene panels, and microarrays, utilized by hospitals, commercial laboratories, and researchers in the healthcare and pharmaceutical industries. Geneyx was formerly known as TGex. It was founded in 2018 and is based in Wilmington, Delaware.

V
VarSome

VarSome is a company that engages in genomic variant discovery and interpretation within the healthcare and research sectors. It provides a platform for the discovery, annotation, and interpretation of next-generation sequencing (NGS) data related to whole genomes, exomes, and gene panels. VarSome serves healthcare professionals and researchers in the genomics community, offering tools for variant classification and a knowledge base with over 140 data resources. It was founded in 2016 and is based in Lausanne, Switzerland.

SeqOne Logo
SeqOne

SeqOne focuses on clinical genomic analysis within the healthcare sector. Its platform provides bioinformatics tools for the analysis of high-throughput sequencing data to support diagnostics in oncology, rare, and inherited diseases. SeqOne's solutions aim to improve the performance of genomic labs and healthcare professionals. It was founded in 2017 and is based in Montpellier, France.

Verily Logo
Verily

Verily focuses on providing data-integrated solutions. The company offers clinical trial recruitment and management, multimodal data analytics, population-level disease monitoring, artificial intelligence (AI)-integrated chronic care solutions, and precision health risk management. Verily serves sectors such as biotechnology and pharma, healthcare payers and providers, public health agencies, and employers. Verily was formerly known as Google Life Sciences. It was founded in 2015 and is based in Dallas, Texas.

DNAnexus Logo
DNAnexus

DNAnexus operates in precision health data management. It provides solutions in the biotechnology and healthcare sectors. The company's offerings include a cloud-based platform for managing, analyzing, and collaborating on multimodal omics data, with a suite of bioinformatics tools and artificial intelligence (AI) capabilities. DNAnexus serves various sectors, including pharmaceutical, biotech, clinical diagnostics, academic medical centers, commercial data businesses, biobanks, and regulatory sectors. It was founded in 2009 and is based in Mountain View, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.